TipRanks
JEIL PHARMA HOLDINGS INC. (KR:002620)
:002620
South Korea Market
002620
JEIL PHARMA HOLDINGS INC.
RESEARCH TOOLSreports

JEIL PHARMA HOLDINGS INC. (002620) Ratios

― Followers

JEIL PHARMA HOLDINGS INC. Ratios

KR:002620's free cash flow for Q2 2026 was ₩0.39. For the 2026 fiscal year, KR:002620's free cash flow was decreased by ₩ and operating cash flow was ₩-0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.20 1.16 1.08 0.93 0.98
Quick Ratio
 0.85 0.79 0.76 0.63 0.67
Cash Ratio
 0.19 0.17 0.16 0.09 0.10
Solvency Ratio
 0.06 0.07 -0.08 >-0.01 -0.16
Operating Cash Flow Ratio
 0.04 <0.01 0.01 -0.01 -0.06
Short-Term Operating Cash Flow Coverage
 0.07 <0.01 0.03 -0.02 -0.14
Net Current Asset Value
₩ -26.43B₩ -34.26B₩ -43.48B₩ -93.28B₩ -92.97B
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.19 0.17 0.24 0.19
Debt-to-Equity Ratio
 0.59 0.53 0.51 0.67 0.48
Debt-to-Capital Ratio
 0.37 0.34 0.34 0.40 0.32
Long-Term Debt-to-Capital Ratio
 0.07 0.05 0.04 0.03 0.05
Financial Leverage Ratio
 2.84 2.75 2.90 2.75 2.56
Debt Service Coverage Ratio
 -0.23 0.16 -0.29 0.05 -0.44
Interest Coverage Ratio
 -0.56 2.01 -1.30 1.96 -1.27
Debt to Market Cap
 1.61 1.30 1.28 1.16 0.68
Interest Debt Per Share
 12.52K 10.95K 10.69K 14.65K 10.98K
Net Debt to EBITDA
 -3.08 3.70 -2.47 19.15 -1.91
Profitability Margins
Gross Profit Margin
39.48%34.41%26.48%26.69%22.76%
EBIT Margin
2.03%2.29%-6.76%-0.41%-9.82%
EBITDA Margin
-6.37%4.57%-4.96%1.15%-8.45%
Operating Profit Margin
-0.67%2.29%-1.48%2.60%-0.95%
Pretax Profit Margin
3.96%6.01%-7.90%-1.74%-10.58%
Net Profit Margin
1.35%2.23%-6.56%-2.02%-10.49%
Continuous Operations Profit Margin
4.08%5.29%-8.51%-1.65%-10.49%
Net Income Per EBT
34.20%37.01%83.02%116.22%99.15%
EBT Per EBIT
-590.23%262.40%533.14%-66.83%1111.04%
Return on Assets (ROA)
0.95%1.67%-5.75%-1.85%-9.60%
Return on Equity (ROE)
2.66%4.59%-16.67%-5.09%-24.62%
Return on Capital Employed (ROCE)
-0.74%2.73%-2.26%4.48%-1.49%
Return on Invested Capital (ROIC)
-0.58%1.88%-1.76%2.96%-1.15%
Return on Tangible Assets
0.96%1.70%-5.84%-1.98%-10.62%
Earnings Yield
7.38%11.40%-42.62%-8.88%-35.17%
Efficiency Ratios
Receivables Turnover
 3.30 3.79 3.87 4.51 4.88
Payables Turnover
 4.61 4.09 3.92 3.83 3.76
Inventory Turnover
 3.23 3.43 4.64 4.71 5.41
Fixed Asset Turnover
 2.51 2.70 3.20 3.51 3.40
Asset Turnover
 0.70 0.75 0.88 0.91 0.92
Working Capital Turnover Ratio
 9.24 16.08 450.64 -47.72 50.30
Cash Conversion Cycle
 144.32 113.57 80.03 63.19 45.13
Days of Sales Outstanding
 110.45 96.30 94.37 81.00 74.75
Days of Inventory Outstanding
 113.00 106.46 78.74 77.57 67.50
Days of Payables Outstanding
 79.14 89.19 93.07 95.39 97.12
Operating Cycle
 223.46 202.76 173.11 158.58 142.25
Cash Flow Ratios
Operating Cash Flow Per Share
 772.66 24.43 295.90 -287.77 -1.36K
Free Cash Flow Per Share
 -120.80 -494.16 -151.19 -928.82 -2.75K
CapEx Per Share
 893.46 518.59 447.09 641.06 1.39K
Free Cash Flow to Operating Cash Flow
 -0.16 -20.23 -0.51 3.23 2.03
Dividend Paid and CapEx Coverage Ratio
 0.80 0.05 0.57 -0.40 -0.91
Capital Expenditure Coverage Ratio
 0.86 0.05 0.66 -0.45 -0.97
Operating Cash Flow Coverage Ratio
 0.06 <0.01 0.03 -0.02 -0.13
Operating Cash Flow to Sales Ratio
 0.02 <0.01 <0.01 >-0.01 -0.03
Free Cash Flow Yield
-1.62%-6.15%-1.93%-7.79%-17.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 13.55 8.43 -2.35 -11.27 -2.84
Price-to-Sales (P/S) Ratio
 0.18 0.20 0.15 0.23 0.30
Price-to-Book (P/B) Ratio
 0.36 0.40 0.39 0.57 0.70
Price-to-Free Cash Flow (P/FCF) Ratio
 -61.67 -16.27 -51.72 -12.84 -5.60
Price-to-Operating Cash Flow Ratio
 9.64 329.07 26.43 -41.46 -11.36
Price-to-Earnings Growth (PEG) Ratio
 0.20 -0.07 -0.01 0.14 >-0.01
Price-to-Fair Value
 0.36 0.40 0.39 0.57 0.70
Enterprise Value Multiple
 -5.96 7.98 -5.57 38.95 -5.44
Enterprise Value
 236.41B 239.60B 215.44B 360.16B 364.26B
EV to EBITDA
 -5.96 7.98 -5.57 38.95 -5.44
EV to Sales
 0.38 0.36 0.28 0.45 0.46
EV to Free Cash Flow
 -127.49 -30.36 -92.82 -25.27 -8.63
EV to Operating Cash Flow
 19.93 613.95 47.43 -81.57 -17.51
Tangible Book Value Per Share
 29.66K 28.34K 27.60K 22.43K 21.94K
Shareholders’ Equity Per Share
 20.49K 19.95K 20.00K 20.82K 22.00K
Tax and Other Ratios
Effective Tax Rate
 -0.03 0.12 -0.08 0.05 <0.01
Revenue Per Share
 40.55K 41.17K 50.80K 52.40K 51.66K
Net Income Per Share
 549.45 916.25 -3.33K -1.06K -5.42K
Tax Burden
 0.34 0.37 0.83 1.16 0.99
Interest Burden
 1.95 2.62 1.17 4.22 1.08
Research & Development to Revenue
 0.09 0.07 0.05 0.06 0.05
SG&A to Revenue
 0.16 0.15 0.12 0.10 0.10
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.53 0.03 -0.07 0.33 0.25
Currency in KRW